| Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: a randomized clinical trial R Howard, O Zubko, R Bradley, E Harper, L Pank, J O’brien, C Fox, ... JAMA neurology 77 (2), 164-174, 2020 | 129 | 2020 |
| Galvanic vestibular stimulation in hemi-spatial neglect D Wilkinson, O Zubko, M Sakel, S Coulton, T Higgins, P Pullicino Frontiers in integrative neuroscience 8, 4, 2014 | 96 | 2014 |
| Improvement of a figure copying deficit during subsensory galvanic vestibular stimulation D Wilkinson, O Zubko, J DeGutis, W Milberg, J Potter Journal of Neuropsychology 4 (1), 107-118, 2010 | 54 | 2010 |
| Endocannabinoid system alterations in Alzheimer’s disease: A systematic review of human studies AJ Berry, O Zubko, SJ Reeves, RJ Howard Brain Research 1749, 147135, 2020 | 30 | 2020 |
| Safety of repeated sessions of galvanic vestibular stimulation following stroke: a single-case study D Wilkinson, O Zubko, M Sakel Brain injury 23 (10), 841-845, 2009 | 24 | 2009 |
| The effect of repeated sessions of galvanic vestibular stimulation on target cancellation in visuo-spatial neglect: preliminary evidence from two cases O Zubko, D Wilkinson, D Langston, M Sakel Brain Injury 27 (5), 613-619, 2013 | 21 | 2013 |
| Minocycline in Alzheimer Disease Efficacy (MADE) Trialist Group. Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: a randomized clinical trial R Howard, O Zubko, R Bradley, E Harper, L Pank, J O’Brien, C Fox, ... JAMA Neurol 77 (2), 164-174, 2020 | 20 | 2020 |
| Effects of electromagnetic fields emitted by GSM phones on working memory: a meta‐analysis O Zubko, RL Gould, HC Gay, HJ Cox, MC Coulson, RJ Howard International journal of geriatric psychiatry 32 (2), 125-135, 2017 | 14 | 2017 |
| Selective 5HT3 antagonists and sensory processing: a systematic review E Tsitsipa, J Rogers, S Casalotti, C Belessiotis-Richards, O Zubko, ... Neuropsychopharmacology 47 (4), 880-890, 2022 | 13 | 2022 |
| Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: The MADE Phase II, three-arm RCT R Howard, O Zubko, R Gray, R Bradley, E Harper, L Kelly, L Pank, ... Efficacy and Mechanism Evaluation 7 (2), 2020 | 10 | 2020 |
| Minocycline in Alzheimer Disease Efficacy (MADE) Trialist Group R Howard, O Zubko, R Bradley, E Harper, L Pank, J O’Brien, C Fox, ... Minocycline at 2, 0 | 5 | |
| Can Galvanic Vestibular Stimulation Induce Lasting Relief from Hemi-Spatial Neglect? M Sakel, D Wilkinson, O Zubko, T Higgins, PM Pullicino, S Coulton, ... Archives of Physical Medicine and Rehabilitation 95 (10), e24, 2014 | | 2014 |
| Do repeated sessions of galvanic vestibular stimulation induce lasting relief from hemi-spatial neglect? DT Wilkinson, S Vanzan, O Zubko, D Langston, M Sakel | | 2012 |
| The effect of target-distracter similarity relations on face matching O Zubko, DT Wilkinson, J DeGutis, RA Johnston | | 2011 |
| Reduced target-distracter interference in congenital prosopagnosia O Zubko, J DeGutis, WP Milberg, DT Wilkinson | | 2010 |
| Sources of Individual Variability in Face Recognition O Zubko, DT Wilkinson, RA Johnston | | 2008 |
| Minocycline in mild Alzheimer’s disease (MADE): a randomised controlled, double-blind trial R Howard, O Zubko, R Bradley, E Harper, L Kelly, L Pank, J O’Brien, ... | | |
| Minocycline at 2 different dosages vs placebo for patients with mild alzheimer disease R Howard, O Zubko, R Bradley, E Harper, L Pank, J O'Brien, C Fox, ... | | |
